芯科实验室 2026年季度报告

(Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 4, 2026 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _________ Commission file number: 000-29823 SILICON LABORATORIES INC. (Exact name of registrant as specified in its charter) (512) 416-8500(Registrant’s telephone number, including area code)Securities registered pursuant to Section 12(b) of the Act: Name of each exchangeon which registered The NASDAQ Stock Market LLC Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2) has been subject to such filing requirements for the past 90 days. YesNo Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files). YesNo Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smallerreporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filerAccelerated filerNon-accelerated filerSmaller reporting companyEmerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YesNo As of August4, 2026, 33,366,761 shares of common stock of Silicon Laboratories Inc. were outstanding. Table of Contents Item 1.Financial Statements (Unaudited):Condensed Consolidated Balance Sheets atJuly4, 2026 andJanuary3, 20263Condensed Consolidated Statements ofOperations for the three and six months endedJuly4, 2026 andJuly5, 20254Condensed Consolidated Statements ofComprehensive Loss for the three and six months endedJuly4,2026 andJuly5, 20255Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and six monthsendedJuly4, 2026 andJuly5, 20256Condensed Consolidated Statements of Cash Flows for the six months endedJuly4, 2026 andJuly5,20257Notes to Condensed Consolidated Financial Statements8Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations17Item 3.Quantitative and Qualitative Disclosures About Market Risk23Item 4.Controls and Procedures23Part II. Other InformationItem 1.Legal Proceedings23Item 1A.Risk Factors24Item 2.Unregistered Sales of Equity Securities and Use of Proceeds41Item 3.Defaults Upon Senior Securities41Item 4.Mine Safety Disclosures41Item 5.Other Information41Item 6.Exhibits42 Cautionary Statement Except for the historical financial information contained herein, the matters discussed in this report on Form 10-Q (as well asdocuments incorporated herein by reference) may be considered “forward-looking” statements within the meaning of Section 27A ofthe Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-lookingstatements include declarations regarding the intent, belief or current expectations of Silicon Laboratories Inc. and its managementand may be signified by the words “believe,” “estimate,” “expect,” “intend,” “anticipate,” “plan,” “project,” “will” or similarlanguage. You are cautioned that any such forward-looking statements are not guarantees of future performance and involve a numberof risks and uncertainties. Actual results could differ materially from those indicated by such forward-looking statements. Factors thatcould cause or contribute to such differences include those discussed under “Risk Factors” and elsewhere in this report. SiliconLaboratories disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of newinformation, future events or otherwise. Silicon Laboratories Inc.Condensed Consolidated Balance Sheets(In thousands, except per share data)(Unaudited) Silicon Laboratories Inc.Condensed Consolidated Statements of Comprehensive Loss(In thousands)(Unaudited) Silicon Laboratories Inc.Condensed Consolidated Statements of Changes in Stockholders’ Equity(In thousands)(Unaudited) Silicon Laboratories Inc.Condensed Consolidated Statements of Cash Flows(In thousands)(Unaudited) Silicon Laboratories Inc.Not